Free Trial

COMPASS Pathways (CMPS) News Today

$8.03
+0.57 (+7.64%)
(As of 07/26/2024 ET)
COMPASS Pathways logo with Medical background
COMPASS Pathways (CMPS) Scheduled to Post Quarterly Earnings on Thursday
COMPASS Pathways (NASDAQ:CMPS) will be releasing earnings before the market opens on Thursday, August 1, Zacks reports.
COMPASS Pathways (NASDAQ:CMPS) Shares Gap Up to $7.43
COMPASS Pathways logo with Medical background
COMPASS Pathways plc (NASDAQ:CMPS) Receives Consensus Rating of "Buy" from Brokerages
COMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) has earned an average rating of "Buy" from the six research firms that are covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a buy rating. The average 12-month price objective among brokerages that have updated th
COMPASS Pathways logo with Medical background
COMPASS Pathways (NASDAQ:CMPS) Now Covered by Royal Bank of Canada
Royal Bank of Canada assumed coverage on COMPASS Pathways in a report on Tuesday. They set an "outperform" rating and a $23.00 target price for the company.
3 Psychedelic Stocks to Buy on the Dip: Summer 2024
COMPASS Pathways (NASDAQ:CMPS) Given Overweight Rating at Cantor Fitzgerald
Cantor Fitzgerald reiterated an "overweight" rating on shares of COMPASS Pathways in a report on Friday.
COMPASS Pathways plc (NASDAQ:CMPS) Sees Large Increase in Short Interest
COMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) was the recipient of a large growth in short interest in May. As of May 31st, there was short interest totalling 3,610,000 shares, a growth of 5.6% from the May 15th total of 3,420,000 shares. Based on an average trading volume of 525,000 shares, the days-to-cover ratio is presently 6.9 days.
COMPASS Pathways logo with Medical background
Affinity Asset Advisors LLC Takes Position in COMPASS Pathways plc (NASDAQ:CMPS)
Affinity Asset Advisors LLC bought a new stake in shares of COMPASS Pathways plc (NASDAQ:CMPS - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 550,000 shares of the company's stock, valu
COMPASS Pathways (NASDAQ:CMPS) Rating Reiterated by HC Wainwright
HC Wainwright reaffirmed a "buy" rating and set a $120.00 price objective on shares of COMPASS Pathways in a research report on Monday.
Insider Selling: COMPASS Pathways plc (NASDAQ:CMPS) Major Shareholder Sells 9,621 Shares of Stock
COMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) major shareholder George Jay Goldsmith sold 9,621 shares of the stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $8.29, for a total transaction of $79,758.09. Following the transaction, the insider now owns 3,966,052 shares in the company, valued at approximately $32,878,571.08. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Major shareholders that own 10% or more of a company's shares are required to disclose their transactions with the SEC.
COMPASS Pathways (CMPS) Set to Announce Quarterly Earnings on Wednesday
COMPASS Pathways (NASDAQ:CMPS) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports.
COMPASS Pathways (NASDAQ:CMPS) Trading 5.4% Higher
COMPASS Pathways (NASDAQ:CMPS) Trading 5.4% Higher
COMPASS Pathways (NASDAQ:CMPS) Rating Reiterated by Cantor Fitzgerald
Cantor Fitzgerald reissued an "overweight" rating on shares of COMPASS Pathways in a report on Tuesday.
COMPASS Pathways plc (NASDAQ:CMPS) Major Shareholder Sells $203,704.93 in Stock
COMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) major shareholder George Jay Goldsmith sold 23,881 shares of the firm's stock in a transaction dated Tuesday, April 16th. The stock was sold at an average price of $8.53, for a total value of $203,704.93. Following the completion of the transaction, the insider now owns 3,986,523 shares in the company, valued at $34,005,041.19. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Major shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.
COMPASS Pathways' (CMPS) "Overweight" Rating Reaffirmed at Cantor Fitzgerald
Cantor Fitzgerald reaffirmed an "overweight" rating on shares of COMPASS Pathways in a report on Thursday.
COMPASS Pathways (NASDAQ:CMPS) Trading 4.6% Higher
COMPASS Pathways (NASDAQ:CMPS) Shares Up 4.6%
COMPASS Pathways (NASDAQ:CMPS) Shares Gap Down to $9.74
COMPASS Pathways (NASDAQ:CMPS) Shares Gap Down to $9.74
COMPASS Pathways (NASDAQ:CMPS) Shares Down 3.6%
COMPASS Pathways (NASDAQ:CMPS) Trading Down 3.6%
COMPASS Pathways (NASDAQ:CMPS) Trading 5.6% Higher
COMPASS Pathways (NASDAQ:CMPS) Stock Price Up 5.6%
COMPASS Pathways (NASDAQ:CMPS) Shares Gap Up to $8.32
COMPASS Pathways (NASDAQ:CMPS) Shares Gap Up to $8.32
COMPASS Pathways plc (NASDAQ:CMPS) Major Shareholder Ekaterina Malievskaia Sells 25,750 Shares
COMPASS Pathways plc (NASDAQ:CMPS - Get Free Report) major shareholder Ekaterina Malievskaia sold 25,750 shares of the company's stock in a transaction that occurred on Thursday, March 28th. The shares were sold at an average price of $8.65, for a total value of $222,737.50. Following the completion of the transaction, the insider now directly owns 4,036,154 shares of the company's stock, valued at approximately $34,912,732.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Large shareholders that own 10% or more of a company's shares are required to disclose their transactions with the SEC.
COMPASS Pathways (NASDAQ:CMPS) Coverage Initiated at Morgan Stanley
Morgan Stanley began coverage on shares of COMPASS Pathways in a research note on Monday. They set an "overweight" rating and a $30.00 price target on the stock.
20 Most Depressed Countries in Asia
Get COMPASS Pathways News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMPS and its competitors with MarketBeat's FREE daily newsletter.

Top Stock Unveiled! (Ad)

Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.

Get Your Free Report

CMPS Media Mentions By Week

CMPS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CMPS
News Sentiment

0.36

0.62

Average
Medical
News Sentiment

CMPS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CMPS Articles
This Week

10

2

CMPS Articles
Average Week

Get COMPASS Pathways News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMPS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CMPS) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners